Amine A. Kamen


Canada Research Chair in Bioprocessing of Viral Vaccines

National Research Council of Canada Research Emeritus

Ph.D. Ecole Polytechnique de Montreal;
Doct.-Ing. Ecole des Mines de Paris

McConnell Engineering Building, Room 363

amine.kamen [at] (e-mail)

Research Interests

  • Cell Culture Engineering
  • Bioprocess Optimization and Scale-up
  • Process Analytical Technologies and Process Control
  • Viral Vaccines Manufacturing
  • Viral Vectors and Nanoparticules for Gene Delivery and Vaccination


BIEN 340: Transport Processes in Biological Systems (3 credits)

Selected Publications

Advancements in the design and scalable production of viral gene transfer vectors. 
Sharon D, Kamen A.
Biotechnology and Bioengineering. 2018; 115(1):25-40. doi:10.1002/bit.26461
PMID: 28941274

Accelerated mass production of influenza virus seed stocks in HEK-293 suspension cell cultures by reverse genetics. 
Milián E, Julien T, Biaggio R, Venereo-Sanchez A, Montes J, Manceur AP, Ansorge  S, Petiot E, Rosa-Calatrava M, Kamen A. 
Vaccine. 2017; 35(26):3423-3430. doi: 10.1016/j.vaccine.2017.04.065
 PMID: 28495315

Optimization and scale-up of cell culture and purification processes for production of an adenovirus-vectored tuberculosis vaccine candidate
Shen CF, Jacob D, Zhu T, Bernier A, Shao Z, Yu X, Patel M, Lanthier S, Kamen A.
Vaccine. 2016; 34(29):3381-7. doi: 10.1016/j.vaccine.2016.04.090
PMID: 27154390

Hemagglutinin and neuraminidase containing virus-like particles produced in HEK-293 suspension culture: An effective influenza vaccine candidate. 
Venereo-Sanchez A, Gilbert R, Simoneau M, Caron A, Chahal P, Chen W, Ansorge S, Li X, Henry O, Kamen A.
Vaccine. 2016; 34(29):3371-80. doi: 10.1016/j.vaccine.2016.04.089
PMID: 27155499

Please see NCBI for a more comprehensive listing.